Eisler Capital Management Ltd. Buys Shares of 70,000 Integral Ad Science Holding Corp. (NASDAQ:IAS)

Eisler Capital Management Ltd. bought a new stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 70,000 shares of the company's stock, valued at approximately $740,000.

Other hedge funds also recently modified their holdings of the company. Barclays PLC grew its holdings in shares of Integral Ad Science by 207.1% in the 3rd quarter. Barclays PLC now owns 127,733 shares of the company's stock valued at $1,380,000 after buying an additional 86,133 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Integral Ad Science by 47.6% in the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock worth $7,756,000 after acquiring an additional 231,271 shares in the last quarter. Franklin Resources Inc. raised its position in shares of Integral Ad Science by 12.9% during the third quarter. Franklin Resources Inc. now owns 110,449 shares of the company's stock worth $1,191,000 after purchasing an additional 12,647 shares during the period. MetLife Investment Management LLC lifted its holdings in shares of Integral Ad Science by 10.1% during the 4th quarter. MetLife Investment Management LLC now owns 44,921 shares of the company's stock valued at $469,000 after purchasing an additional 4,123 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Integral Ad Science by 1.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 603,848 shares of the company's stock worth $6,304,000 after purchasing an additional 7,941 shares in the last quarter. Institutional investors own 95.78% of the company's stock.

Integral Ad Science Stock Performance

Shares of NASDAQ:IAS traded down $0.09 on Thursday, hitting $8.01. The company had a trading volume of 888,575 shares, compared to its average volume of 1,023,601. The stock has a market cap of $1.31 billion, a price-to-earnings ratio of 40.05, a P/E/G ratio of 1.06 and a beta of 1.55. The stock has a 50 day moving average price of $7.74 and a 200 day moving average price of $9.69. Integral Ad Science Holding Corp. has a 1-year low of $6.26 and a 1-year high of $13.62. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.02. The firm had revenue of $134.07 million during the quarter, compared to the consensus estimate of $129.20 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. Analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Insider Buying and Selling

In other news, CEO Lisa Utzschneider sold 8,367 shares of the stock in a transaction on Wednesday, May 7th. The stock was sold at an average price of $7.37, for a total transaction of $61,664.79. Following the sale, the chief executive officer now directly owns 349,574 shares of the company's stock, valued at approximately $2,576,360.38. This represents a 2.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders have sold 86,222 shares of company stock valued at $636,252. 2.00% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on IAS shares. Baird R W cut shares of Integral Ad Science from a "strong-buy" rating to a "hold" rating in a report on Friday, March 28th. Raymond James upped their price target on Integral Ad Science from $11.00 to $13.00 and gave the stock an "outperform" rating in a research report on Tuesday. Truist Financial lifted their price objective on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a "buy" rating in a report on Monday, March 3rd. Oppenheimer restated an "outperform" rating on shares of Integral Ad Science in a report on Friday, February 28th. Finally, Scotiabank assumed coverage on shares of Integral Ad Science in a research note on Friday, February 28th. They issued a "sector perform" rating and a $12.00 price target on the stock. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $13.55.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.